"Opinions on Elon Musk have taken a turn for the worse along political affiliations," Stifel analyst Stephen Gengaro said.
Stifel Financial is a top pick for long-term growth with solid Q424 results, a 10% dividend hike & solid wealth management ...
GATX Corporation (NYSE: GATX) announced the cancellation of its presentation and webcast at the Stifel 2025 Transportation & ...
Proprietary Insights – Stifel Discover delivers exclusive analysis and commentary from Stifel’s Chief Investment Officer, Chief Economist, Chief Washington Policy Strategist, equity research analysts, ...
MoneyLion operates a “content-as-a-service platform” called mFeed, and Stifel Discover is expected to deliver personalized ...
Stifel analysts lowered their price target for Tesla stock in response to “the negative downturn in consumers' perception of ...
According to Benzinga Pro, Stifel Financial's peer group average for short interest as a percentage of float is 3.37%, which ...
CEO Jon Congleton highlighted the company's focus on advancing its pivotal trials for lorundrostat, targeting dysregulated aldosterone in patients with uncontrolled and resistant hypertension. He ...
We recently compiled a list of the 10 AI News Updates on Wall Street’s Radar. In this article, we are going to take a look at ...
Stifel analysts increased the price target for Confluent Inc (NASDAQ:CFLT), a data streaming platform, from $37.00 to $40.00, ...
Stifel analysts maintained their Buy rating on Iovance Biotherapeutics (NASDAQ:IOVA), currently trading at $5.24, with a steady price target of $21.00. According to InvestingPro data, analyst targets ...
Tesla (NASDAQ:TSLA – Get Free Report) had its price objective cut by research analysts at Stifel Nicolaus from $492.00 to ...